MarginsXMarginsX
Home › Markets › Health Care › NDRA

ENDRA Life Sciences Inc. (NDRA)

NDRA trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.42
-1.78% on the day
Market cap
$6.6M
Nano cap
Revenue · 2020
$0
Prior year not contiguous
Net income · 2020
-$11.7M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2020-12-31, https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/0001654954-21-003302-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2020-12-31.

Profile

FieldValue
TickerNDRA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2017
SEC CIK0001681682

Financials · 2020

LineValue
Revenue$0
Net income-$11.7M
Operating income-$11.5M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$7.2M
Total assets$8.8M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
4.3 months
$1.7M cash at June 30, 2026
Share count, 1 year
+99.2%
2025-08-14 to 2026-08-14 · +34982.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These matters raise substantial doubt about the Company's ability to continue as going concern."
10-Q 2026-08-14
Cash and burn$1.7M cash; operating cash flow -$1.2M a quarter.Report 2026-06-30
Shares outstanding1,499,838 (2026-08-14); 752,755 a year earlier; 7,481,603 three years earlier. 3y figure adjusted for splits (1-for-1750 overall).Cover page 2026-08-14
Reverse splits, 3 years2; latest 1-for-35 on 2024-11-07Source 2024-11-07
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-21
AuditorRBSM LLP, HOUSTON, Texas, United StatesPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed$160K-$928K$1.7MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$1.3M-$1.1M$356KNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
Not filed-$3.2M-$1.6M$762KNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$1.6M-$1.2M$794KNo debt tagsNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$1.2M-$1.1M$1.8MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$1.0M-$1.3M$2.1MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2024
2024-12-31
Not filed-$4.1M-$1.5M$3.2M$0Needs four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$2.4M-$1.7M$4.7M$0Needs four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-6.8%
1 month-12.5%
3 months-1.3%
Year to date-2.6%
1 year-32.9%
From 52-week high-34.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
IRIXIRIDEX Corporation$0.6878-0.32%$12.1M
ITOCiTonic Holdings Ltd$1.88-5.05%$13.8M
NUWENuwellis Inc.$4.48-8.57%$2.4M
NXLNexalin Technology Inc.$1.56+2.30%$1.9M
QTIQT Imaging Holdings Inc.$1.80-4.26%$26.4M
VBIOValion Bio Inc.$0.5290+0.84%$1.1M
ECORelectroCore Inc.$4.84-7.81%$44.7M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier